Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 36,032Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AZURITY

02 46CEPHALON

03 44EAGLE PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 11844784

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 212209

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2042-07-29

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 8445524

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1402

Delist Requested :

Patent Use Description : FOR USE IN THE TREATME...

Patent Expiration Date : 2029-03-26

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 8791270

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1542

Delist Requested :

Patent Use Description : FOR USE IN THE TREATME...

Patent Expiration Date : 2026-01-12

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 8791270

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1542

Delist Requested :

Patent Use Description : FOR USE IN THE TREATME...

Patent Expiration Date : 2026-01-12

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 8883836

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1402

Delist Requested :

Patent Use Description : FOR USE IN THE TREATME...

Patent Expiration Date : 2029-03-26

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 9533955

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1952

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-26

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 9533955

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1952

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-26

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 8791270

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1542

Delist Requested :

Patent Use Description : FOR USE IN THE TREATME...

Patent Expiration Date : 2026-01-12

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 8445524

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1402

Delist Requested :

Patent Use Description : FOR USE IN THE TREATME...

Patent Expiration Date : 2029-03-26

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

BENDAMUSTINE HYDROCHLORIDE

US Patent Number : 8791270

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22249

Patent Use Code : U-1542

Delist Requested :

Patent Use Description : FOR USE IN THE TREATME...

Patent Expiration Date : 2026-01-12

blank